CYPHERTM Stent Post-Marketing Surveillance Registry (US-PMS)

Cordis

Status and phase: Completed; Phase 4

Conditions: Coronary Artery Disease

Treatments: Device: CYPHERTM Sirolimus-Eluting Coronary Stent

Study type: Interventional

Funder types: Industry

Identifiers

NCT00245401

P03-6321

Details and patient eligibility

About

The purpose of this PMS registry, named e-CYPHER Stent Registry, is to collect post marketing surveillance data on the CYPHERTM Sirolimus-eluting Coronary Stent following marketing approval, when used in normal clinical practice within the labeled indications.

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Cypher stent

Exclusion criteria

• N/A

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)